448 results on '"Mönig, Stefan"'
Search Results
2. Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023
3. Side Effects of Gastric Cancer Surgery: Prevention and Treatment
4. Assessment of predictors of early postoperative complications after primary robotically assisted Roux-en-Y gastric bypass: a multicenter, retrospective cohort study
5. Outcome of endoscopic vacuum therapy for duodenal perforation
6. Gastric cancer
7. Implementation and validation of a competency assessment tool for laparoscopic cholecystectomy
8. Robotic Toupet Fundoplication
9. Studien der Arbeitsgruppe Magen-Ösophagus-Tumoren der Arbeitsgemeinschaft Internistische Onkologie (AIO)
10. Individualisierte Ösophaguschirurgie
11. Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The IKF-575/RENAISSANCE phase III trial.
12. Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach
13. Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative)
14. Impact of Nonalcoholic Steatohepatitis on the Outcome of Patients Undergoing Roux-en-Y Gastric Bypass Surgery: a Propensity Score–Matched Analysis
15. Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer
16. Robotic Toupet Fundoplication
17. Therapieoptionen beim oligometastasierten Magenkarzinom
18. Therapie des Ösophaguskarzinom.
19. Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023
20. International External Validation of Risk Prediction Model of 90-Day Mortality after Gastrectomy for Cancer Using Machine Learning
21. Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative)
22. Clinical practice guidelines for esophagogastric junction cancer:Upper GI Oncology Summit 2023
23. Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
24. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
25. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma
26. RACE: Neoadjuvante Radiochemotherapie vs. Chemotherapie für Patienten mit lokal fortgeschrittenem, potenziell resektablem Adenokarzinom des ösophagogastralen Übergangs
27. The role of surgery in advanced disease for esophageal and junctional cancer
28. Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review
29. Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)
30. Development and Validation of a Predictive Model for Internal Hernia after Roux-en-Y Gastric Bypass in a Multicentric Retrospective Cohort: The Swirl, Weight Excess Loss, Liquid Score
31. S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs: Version 2.0 – August 2019. AWMF-Registernummer: 032/009OL
32. Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction: a systematic review of the literature
33. Siewert Classification of Adenocarcinoma of the Esophagogastric Junction: Still In or Already Out?
34. Erratum to “Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue” [Eur J Surg Oncol 49 (5) (May 2023) 974–982]
35. RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV
36. Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study
37. International consensus on a complications list after gastrectomy for cancer
38. Multimodal treatment in locally advanced gastric cancer
39. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
40. Management of paraesophageal hiatus hernia:recommendations following a European expert Delphi consensus
41. Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study (ChangeQol Study)
42. Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue
43. Assessment of predictors of early postoperative complications after primary robotically assisted Roux-en-Y gastric bypass: a multicenter, retrospective cohort study
44. Clinical Classification Systems of Adenocarcinoma of the Esophagogastric Junction
45. Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival
46. Outcome of endoscopic vacuum therapy for duodenal perforation
47. Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765)
48. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial
49. Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference
50. Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.